Clinical Trial Update: The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart. [Phase 3]

View source ↗

Summary

Phase 3 trial update describing leuprolide mesylate given as two injections six months apart for advanced prostate cancer; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprolide mesylate (leuprolide mesylate)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Advanced Prostate Cancer | Phase 3 | Status: COMPLETED